Sinohealth Holdings Limited (HKG:2361)

Market Cap	2.10B
Revenue (ttm)	429.68M
Net Income (ttm)	102.69M
Shares Out	407.68M
EPS (ttm)	0.25
PE Ratio	20.29
Forward PE	n/a
Dividend	0.12 (2.33%)
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	15,575
Open	n/a
Previous Close	5.14
Day's Range	n/a
52-Week Range	2.24 - 5.60
Beta	-0.24
RSI	49.89
Earnings Date	Mar 27, 2026

About Sinohealth Holdings

Sinohealth Holdings Limited provides healthcare solutions for sales and marketing needs of medical product manufacturer clients in Mainland China, the Netherland, England, Hong Kong, Singapore, and internationally. It engages in the research and development, and provision of data insight solutions, data-driven publications and events, and software as a service (SaaS) products; research and development, and operation of Smart Medical Cloud under the business line of SaaS products; management of marketing and promotion services of medicine; opera...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2007
• Employees: 756
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2361

Financial Performance

In 2024, Sinohealth Holdings's revenue was 403.73 million, an increase of 1.90% compared to the previous year's 396.19 million. Earnings were 110.65 million, an increase of 8.45%.

Financial numbers in CNY